Industry Strength Score
11/100
Composite price performance score based on 3, 6, and 12-month returns, with more weight on recent trends.
NATUS MEDICAL INC (NTUS) Stock Price & Overview
NASDAQ:NTUS • US6390501038
Current stock price
32.96 USD
+0.03 (+0.09%)
At close:
32.96 USD
0 (0%)
After Hours:
The current stock price of NTUS is 32.96 USD. Today NTUS is up by 0.09%. In the past month the price increased by 2.07%. In the past year, price increased by 32.69%.
NTUS Key Statistics
52-Week Range20.902 - 33.93
Current NTUS stock price positioned within its 52-week range.
1-Month Range31.8 - 33.25
Current NTUS stock price positioned within its 1-month range.
- Market Cap
- 1.14B
- P/E
- 26.16
- Fwd P/E
- 20.58
- EPS (TTM)
- 1.26
- Dividend Yield
- N/A
NTUS Stock Performance
Today
+0.09%
1 Week
+0.83%
1 Month
+2.07%
3 Months
-1.38%
Longer-term
6 Months +35.19%
1 Year +32.69%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A
NTUS Stock Chart
NTUS Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NTUS. When comparing the yearly performance of all stocks, NTUS is one of the better performing stocks in the market, outperforming 93.25% of all stocks.
Chartmill TA Rating
Chartmill Setup Rating
NTUS Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NTUS. NTUS is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
NTUS Earnings
Next Earnings DateAug 4, 2022
Last Earnings DateMay 5, 2022
PeriodQ1 / 2022
EPS Reported$0.22
Revenue Reported
EPS Surprise -17.04%
Revenue Surprise 1.50%
NTUS Forecast & Estimates
For the next year, analysts expect an EPS growth of 22.4% and a revenue growth 5.1% for NTUS
Analysts
Analysts43.33
Price TargetN/A
EPS Next Y22.4%
Revenue Next Year5.1%
NTUS Financial Highlights
Over the last trailing twelve months NTUS reported a non-GAAP Earnings per Share(EPS) of 1.26. The EPS increased by 147.06% compared to the year before.
Income Statements
Revenue(TTM)478.31M
Net Income(TTM)12.67M
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 2.65% | ||
| ROA | 2.23% | ||
| ROE | 2.94% | ||
| Debt/Equity | 0 |
Chartmill High Growth Momentum
EPS Q2Q%37.5%
Sales Q2Q%4.26%
EPS 1Y (TTM)147.06%
Revenue 1Y (TTM)13.56%
NTUS Ownership
Ownership
Inst Owners91.2%
Shares34.58M
Float33.90M
Ins Owners0.64%
Short Float %N/A
Short RatioN/A
NTUS Industry Overview
NTUS operates in the Health Care Equipment sub-industry within the Health Care sector. This group contains 127 stocks and is scored by ChartMill on both price strength and growth momentum.
Industry Growth Score
62/100
Composite growth score based on earnings growth, revenue growth, and profitability across the sub-industry.
Relative Performance
Each rank shows how many other sub-industries were outperformed over that timeframe.
1 Month Rank
26%
Outperformed 26% of sub-industries
3 Month Rank
11%
Outperformed 11% of sub-industries
6 Month Rank
11%
Outperformed 11% of sub-industries
Industry Fundamentals & Breadth
- Members
- 127
- New Highs
- 3.9%
- New Lows
- 10.2%
- Average ROE
- 17.2%
- Average Profit Margin
- 20.2%
- Average Operating Margin
- 22.4%
- Average P/E
- 28.9
- Average Fwd P/E
- 24.6
- Average Debt/Equity
- 0.5
NTUS Competitors/Peers
The largest stocks on the US markets in the "Health Care Equipment" sub-industry
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ISRG | INTUITIVE SURGICAL INC | 40.01 | 167.282B | ||
| ABT | ABBOTT LABORATORIES | 14.94 | 161.256B | ||
| SYK | STRYKER CORP | 21.26 | 126.004B | ||
| BSX | BOSTON SCIENTIFIC CORP | 14.81 | 89.097B | ||
| EW | EDWARDS LIFESCIENCES CORP | 24.39 | 48.118B | ||
| IDXX | IDEXX LABORATORIES INC | 38.38 | 45.663B | ||
| BDX | BECTON DICKINSON AND CO | 10.95 | 42.774B | ||
| RMD | RESMED INC | 17.69 | 32.344B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.26 | 32.159B | ||
| DXCM | DEXCOM INC | 23.33 | 23.634B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 9.76 | 17.923B | ||
| PODD | INSULET CORP | 28.2 | 13.042B | ||
| PEN | PENUMBRA INC | 63.95 | 12.896B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About NTUS
Company Profile
Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The company is headquartered in Middleton, Wisconsin and currently employs 1,400 full-time employees. The company went IPO on 2001-07-20. The company provides product solutions for three end markets: Neuro, Newborn Care, and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic, and surgical solutions in neurodiagnostic, neurocritical care and neurosurgery. Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management, live video streaming and various disposable newborn care supplies. Hearing & Balance includes products for hearing assessment and diagnostics, and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Neuro products and services include Electroencephalography, Electromyography, Polysomnography, Subdural electrodes, and Cranial access kits.
Company Info
IPO: 2001-07-20
NATUS MEDICAL INC
3150 Pleasant View Road
Middleton WISCONSIN 94566 US
CEO: Jonathan A. Kennedy
Employees: 1400
Phone: 16088298500.0
NATUS MEDICAL INC / NTUS FAQ
What does NTUS do?
Natus Medical, Inc. provides medical device solutions focuses on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The company is headquartered in Middleton, Wisconsin and currently employs 1,400 full-time employees. The company went IPO on 2001-07-20. The company provides product solutions for three end markets: Neuro, Newborn Care, and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic, and surgical solutions in neurodiagnostic, neurocritical care and neurosurgery. Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management, live video streaming and various disposable newborn care supplies. Hearing & Balance includes products for hearing assessment and diagnostics, and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Neuro products and services include Electroencephalography, Electromyography, Polysomnography, Subdural electrodes, and Cranial access kits.
What is the stock price of NATUS MEDICAL INC today?
The current stock price of NTUS is 32.96 USD. The price increased by 0.09% in the last trading session.
Does NTUS stock pay dividends?
NTUS does not pay a dividend.
What is the ChartMill technical and fundamental rating of NTUS stock?
NTUS has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
Can you provide the sector and industry classification for NATUS MEDICAL INC?
NATUS MEDICAL INC (NTUS) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the expected growth for NTUS stock?
The Revenue of NATUS MEDICAL INC (NTUS) is expected to grow by 5.1% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
Can you provide the market cap for NATUS MEDICAL INC?
NATUS MEDICAL INC (NTUS) has a market capitalization of 1.14B USD. This makes NTUS a Small Cap stock.